SCHEMBL6492647

SCHEMBL6492647

CC(c1cccc2ccccc12)S(C)(=O)=O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
KEAP1 Q14145 1/20 0.48
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
ADRA2A P08913 3/20 0.44
ADRA2B P18089 3/20 0.44
ADRA2C P18825 3/20 0.44
ADRA1A P35348 2/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1B P35368 1/20 0.44
NQO2 P16083 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28349697 0.86 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2C9CYP2C19KEAP1
SCHEMBL28349693 0.86 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2C9CYP2C19KEAP1
SCHEMBL7425681 0.86 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2C9CYP2C19KEAP1
SCHEMBL497026 0.86 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2C9CYP2C19KEAP1
SCHEMBL30565328 0.86 KEAP1 (0.49) ALDH1A1CYP1A2CYP2C9CYP2C19KEAP1
SCHEMBL9516570 0.83 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP2C9CYP2C19KEAP1
Sulfuric Acid SCHEMBL10708662 0.80 CYP1A2 (0.48) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL15562148 0.80 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP2C9CYP2C19KEAP1
SCHEMBL12462064 0.80 KEAP1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19KEAP1
SCHEMBL12462066 0.80 KEAP1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6858603-B2 Acetindine derivatives, their preparation and medicaments containing them AVENTIS PHARMA S.A. (FR) 2005-02-22 US disclosed
US-20030162808-A1 Acetindine derivatives, their preparation and medicaments containing them AVENTIS PHARMA S.A. (FR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162808-A1 Acetindine derivatives, their preparation and medicaments containing them ADRA1D, ADRB2, AZI2 ALDH1A1 32/4885CYP1A2 14/4885CYP2C9 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.